skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Blood remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study
Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study

Rea, Delphine ; Nicolini, Franck E. ; Tulliez, Michel ; Guilhot, François ; Guilhot, Joelle ; Guerci-Bresler, Agnès ; Gardembas, Martine ; Coiteux, Valérie ; Guillerm, Gaelle ; Legros, Laurence ; Etienne, Gabriel ; Pignon, Jean-Michel ; Villemagne, Bruno ; Escoffre-Barbe, Martine ; Ianotto, Jean-Christophe ; Charbonnier, Aude ; Johnson-Ansah, Hyacinthe ; Noel, Marie-Pierre ; Rousselot, Philippe ; Mahon, François-Xavier

Blood, 2017-02, Vol.129 (7), p.846-854 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia
Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia

Dulucq, Stéphanie ; Bouchet, Stéphane ; Turcq, Béatrice ; Lippert, Eric ; Etienne, Gabriel ; Reiffers, Josy ; Molimard, Mathieu ; Krajinovic, Maja ; Mahon, François-Xavier

Blood, 2008-09, Vol.112 (5), p.2024-2027 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
3
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Material Type:
Artigo 		Adicionar ao Meu Espaço

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

Baccarani, Michele ; Deininger, Michael W. ; Rosti, Gianantonio ; Hochhaus, Andreas ; Soverini, Simona ; Apperley, Jane F. ; Cervantes, Francisco ; Clark, Richard E. ; Cortes, Jorge E. ; Guilhot, François ; Hjorth-Hansen, Henrik ; Hughes, Timothy P. ; Kantarjian, Hagop M. ; Kim, Dong-Wook ; Larson, Richard A. ; Lipton, Jeffrey H. ; Mahon, François-Xavier ; Martinelli, Giovanni ; Mayer, Jiri ; Müller, Martin C. ; Niederwieser, Dietger ; Pane, Fabrizio ; Radich, Jerald P. ; Rousselot, Philippe ; Saglio, Giuseppe ; Saußele, Susanne ; Schiffer, Charles ; Silver, Richard ; Simonsson, Bengt ; Steegmann, Juan-Luis ; Goldman, John M. ; Hehlmann, Rüdiger

Blood, 2013-08, Vol.122 (6), p.872-884 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years
Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years
Material Type:
Artigo 		Adicionar ao Meu Espaço

Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years

Rousselot, Philippe ; Huguet, Francoise ; Rea, Delphine ; Legros, Laurence ; Cayuela, Jean Michel ; Maarek, Odile ; Blanchet, Odile ; Marit, Gerald ; Gluckman, Eliane ; Reiffers, Josy ; Gardembas, Martine ; Mahon, François-Xavier ; The Intergroupe Français des Leucémies Myéloïdes Chronique (FIφLMC)

Blood, 2007-01, Vol.109 (1), p.58-60 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis
Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis

Di Blasi, Roberta ; Le Gouill, Steven ; Bachy, Emmanuel ; Cartron, Guillaume ; Beauvais, David ; Le Bras, Fabien ; Gros, François-Xavier ; Choquet, Sylvain ; Bories, Pierre ; Feugier, Pierre ; Casasnovas, Olivier ; Bay, Jacques Olivier ; Mohty, Mohamad ; Joris, Magalie ; Gastinne, Thomas ; Sesques, Pierre ; Tudesq, Jean-Jacques ; Vercellino, Laetitia ; Morschhauser, Franck ; Gat, Elodie ; Broussais, Florence ; Houot, Roch ; Thieblemont, Catherine

Blood, 2022-12, Vol.140 (24), p.2584-2593 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
In vivo genome editing of the albumin locus as a platform for protein replacement therapy
In vivo genome editing of the albumin locus as a platform for protein replacement therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

In vivo genome editing of the albumin locus as a platform for protein replacement therapy

Sharma, Rajiv ; Anguela, Xavier M. ; Doyon, Yannick ; Wechsler, Thomas ; DeKelver, Russell C. ; Sproul, Scott ; Paschon, David E. ; Miller, Jeffrey C. ; Davidson, Robert J. ; Shivak, David ; Zhou, Shangzhen ; Rieders, Julianne ; Gregory, Philip D. ; Holmes, Michael C. ; Rebar, Edward J. ; High, Katherine A.

Blood, 2015-10, Vol.126 (15), p.1777-1784 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
7
Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression
Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression
Material Type:
Artigo 		Adicionar ao Meu Espaço

Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression

Chauveau, Christine ; Rémy, Séverine ; Royer, Pierre Joseph ; Hill, Marcelo ; Tanguy-Royer, Séverine ; Hubert, François-Xavier ; Tesson, Laurent ; Brion, Régis ; Beriou, Gaëlle ; Gregoire, Marc ; Josien, Régis ; Cuturi, Maria Cristina ; Anegon, Ignacio

Blood, 2005-09, Vol.106 (5), p.1694-1702 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant–associated ALCL
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant–associated ALCL
Material Type:
Artigo 		Adicionar ao Meu Espaço

Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant–associated ALCL

Laurent, Camille ; Nicolae, Alina ; Laurent, Cécile ; Le Bras, Fabien ; Haioun, Corinne ; Fataccioli, Virginie ; Amara, Nadia ; Adélaïde, José ; Guille, Arnaud ; Schiano, Jean-Marc ; Tesson, Bruno ; Traverse-Glehen, Alexandra ; Chenard, Marie-Pierre ; Mescam, Lénaïg ; Moreau, Anne ; Chassagne-Clement, Catherine ; Somja, Joan ; Escudié, Frédéric ; André, Marc ; Martin, Nadine ; Lacroix, Laetitia ; Lemonnier, François ; Hamy, Anne-Sophie ; Reyal, Fabien ; Bannier, Marie ; Oberic, Lucie ; Prade, Nais ; Frénois, François-Xavier ; Beldi-Ferchiou, Asma ; Delfau-Larue, Marie-Helene ; Bouabdallah, Reda ; Birnbaum, Daniel ; Brousset, Pierre ; Xerri, Luc ; Gaulard, Philippe

Blood, 2020-01, Vol.135 (5), p.360-370 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies

Deng, Changchun ; Lipstein, Mark R. ; Scotto, Luigi ; Jirau Serrano, Xavier O. ; Mangone, Michael A. ; Li, Shirong ; Vendome, Jeremie ; Hao, Yun ; Xu, Xiaoming ; Deng, Shi-Xian ; Realubit, Ronald B. ; Tatonetti, Nicholas P. ; Karan, Charles ; Lentzsch, Suzanne ; Fruman, David A. ; Honig, Barry ; Landry, Donald W. ; O'Connor, Owen A.

Blood, 2017-01, Vol.129 (1), p.88-99 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models
MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models
Material Type:
Artigo 		Adicionar ao Meu Espaço

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models

Mahon, François-Xavier ; Belloc, Francis ; Lagarde, Valérie ; Chollet, Claudine ; Moreau-Gaudry, François ; Reiffers, Josy ; Goldman, John M. ; Melo, Junia V.

Blood, 2003-03, Vol.101 (6), p.2368-2373 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.